BWXT Medical Ltd.
FDA inspection history in Ottawa, Canada, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Ottawa, Canada.
Cited most
Across all BWXT Medical observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products2
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.192Production record review1
The complete BWXT Medical file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Ottawa, Canada
One Form 483 · 2023 · 8 observations
Latest: Form 483, Mar 3, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-03-03 | 483 Form 483 | Ottawa, Canada | 8 | $99 |
Investigators on these documents
FEI number 3001092088 · most recent document Mar 3, 2023
About BWXT Medical Ltd.
How many FDA Form 483s has BWXT Medical Ltd. received?
FDA Intel has 1 Form 483 on file for BWXT Medical Ltd.; the most recent is dated Mar 3, 2023.
When was BWXT Medical Ltd. last inspected by FDA?
The most recent FDA inspection document on file for BWXT Medical Ltd. is a Form 483 dated Mar 3, 2023, for the site in Ottawa, Canada.
What did FDA cite at BWXT Medical Ltd.?
The regulations cited most in the observations on file for BWXT Medical Ltd. are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 2 times; 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 2 times; 21 CFR 211.113 (Control of microbiological contamination), 1 time.